Total Payments
$1,419
2024 Payments
$112.88
Companies
16
Transactions
46
Medicare Patients
1,617
Medicare Billing
$175,233
Payment Breakdown by Category
Food & Beverage$1,419 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,419 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $285.08 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $241.32 | 10 | $0 (2022) |
| PFIZER INC. | $125.18 | 8 | $0 (2022) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| ABBVIE INC. | $104.32 | 6 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $92.63 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $87.26 | 2 | $0 (2022) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
| Chiesi USA, Inc. | $60.39 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112.88 | 5 | ABBVIE INC. ($51.70) |
| 2023 | $58.80 | 3 | E.R. Squibb & Sons, L.L.C. ($22.56) |
| 2022 | $188.14 | 11 | Janssen Pharmaceuticals, Inc ($49.36) |
| 2021 | $93.70 | 7 | PFIZER INC. ($43.01) |
| 2020 | $60.43 | 4 | PFIZER INC. ($33.73) |
| 2019 | $132.32 | 4 | Janssen Pharmaceuticals, Inc ($75.59) |
| 2018 | $309.30 | 6 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $463.65 | 6 | E.R. Squibb & Sons, L.L.C. ($180.54) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/10/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $18.89 | General |
| Category: Medical Device | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: Cardiovascular | ||||||
| 02/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Cardiovascular | ||||||
| 01/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Cardiovascular | ||||||
| 05/08/2023 | BTG International, Inc. | DIGIFAB (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Toxicity Antidote (Digoxin Toxicity) | ||||||
| 11/29/2022 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 11/16/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Medical Device | ||||||
| 07/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 02/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.78 | General |
| Category: Cardiovascular | ||||||
| 02/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/13/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/13/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 430 | 435 | $163,410 | $45,518 |
| 2022 | 4 | 387 | 392 | $123,350 | $35,154 |
| 2021 | 3 | 308 | 314 | $84,970 | $37,074 |
| 2020 | 4 | 492 | 509 | $127,250 | $57,488 |
Total Patients
1,617
Total Services
1,650
Medicare Billing
$175,233
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 235 | 236 | $103,840 | $30,319 | 29.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 105 | 107 | $32,635 | $8,851 | 27.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 21 | $14,175 | $3,274 | 23.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 69 | 71 | $12,760 | $3,073 | 24.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 158 | 161 | $69,930 | $19,548 | 28.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 119 | 120 | $36,440 | $10,536 | 28.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 70 | 71 | $12,780 | $3,740 | 29.3% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 40 | 40 | $4,200 | $1,330 | 31.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 174 | 178 | $55,270 | $24,964 | 45.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 122 | 124 | $27,900 | $11,415 | 40.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 12 | 12 | $1,800 | $694.32 | 38.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 308 | 323 | $72,675 | $32,327 | 44.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 155 | 157 | $51,025 | $23,943 | 46.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 13 | 13 | $1,950 | $701.36 | 36.0% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 16 | 16 | $1,600 | $516.99 | 32.3% |
About Foy Mann
Foy Mann is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1861860603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Foy Mann has received a total of $1,419 in payments from pharmaceutical and medical device companies, with $112.88 received in 2024. These payments were reported across 46 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,419).
As a Medicare-enrolled provider, Mann has provided services to 1,617 Medicare beneficiaries, totaling 1,650 services with total Medicare billing of $175,233. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 09/10/2015
- Last Updated 09/10/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861860603
Products in Payments
- ELIQUIS (Drug) $410.26
- XARELTO (Drug) $241.32
- OFIRMEV (Drug) $120.47
- XIFAXAN (Drug) $99.39
- Orbactiv (Drug) $92.63
- IGT_D Peripheral (Device) $70.29
- DALVANCE (Drug) $66.22
- Veltassa (Drug) $63.25
- CLEVIPREX (Drug) $60.39
- TEFLARO (Drug) $51.70
- GIAPREZA (Drug) $43.13
- HyperRAB (Biological) $22.58
- LOKELMA (Drug) $22.26
- DIGIFAB (Drug) $19.47
- (CM9) Amb Mon & Diag Und (Device) $18.89
- (5044) MCOT (Device) $16.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117